[go: up one dir, main page]

DE60321700D1 - Pyrazolderivate und deren verwendung als therapeutische mittel für durch hiv vermittelte krankheiten - Google Patents

Pyrazolderivate und deren verwendung als therapeutische mittel für durch hiv vermittelte krankheiten

Info

Publication number
DE60321700D1
DE60321700D1 DE60321700T DE60321700T DE60321700D1 DE 60321700 D1 DE60321700 D1 DE 60321700D1 DE 60321700 T DE60321700 T DE 60321700T DE 60321700 T DE60321700 T DE 60321700T DE 60321700 D1 DE60321700 D1 DE 60321700D1
Authority
DE
Germany
Prior art keywords
hiv
derivatives
disorded
diseases
therapeutic agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60321700T
Other languages
English (en)
Inventor
Paul John Edwards
Lyn Howard Jones
Charles Eric Mowbray
Paul Anthony Stupple
Isabelle Tran
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp Belgium
Pfizer Corp SRL
Original Assignee
Pfizer Corp Belgium
Pfizer Corp SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp Belgium, Pfizer Corp SRL filed Critical Pfizer Corp Belgium
Application granted granted Critical
Publication of DE60321700D1 publication Critical patent/DE60321700D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18—One oxygen or sulfur atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE60321700T 2002-10-07 2003-09-24 Pyrazolderivate und deren verwendung als therapeutische mittel für durch hiv vermittelte krankheiten Expired - Fee Related DE60321700D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0223234.6A GB0223234D0 (en) 2002-10-07 2002-10-07 Chemical compounds
PCT/IB2003/004214 WO2004031156A1 (en) 2002-10-07 2003-09-24 Pyrazole derivatives and their use as therapeutic agents for hiv mediated diseases

Publications (1)

Publication Number Publication Date
DE60321700D1 true DE60321700D1 (de) 2008-07-31

Family

ID=9945429

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60321700T Expired - Fee Related DE60321700D1 (de) 2002-10-07 2003-09-24 Pyrazolderivate und deren verwendung als therapeutische mittel für durch hiv vermittelte krankheiten

Country Status (11)

Country Link
EP (1) EP1556359B1 (de)
JP (1) JP2006504713A (de)
AT (1) ATE398607T1 (de)
AU (1) AU2003264940A1 (de)
BR (1) BR0314930A (de)
CA (1) CA2501541A1 (de)
DE (1) DE60321700D1 (de)
ES (1) ES2305563T3 (de)
GB (1) GB0223234D0 (de)
MX (1) MXPA05003641A (de)
WO (1) WO2004031156A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2057125B1 (de) 2006-08-16 2011-03-30 F. Hoffmann-La Roche AG Nicht-nukleosidische reverse-transkriptase-hemmer
KR101610415B1 (ko) 2007-12-21 2016-04-07 에프. 호프만-라 로슈 아게 헤테로사이클릭 항바이러스 화합물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0016787D0 (en) * 2000-07-07 2000-08-30 Pfizer Ltd Compounds useful in therapy
GB0024795D0 (en) * 2000-10-10 2000-11-22 Hoffmann La Roche Pyrazole derivatives for the treatment of viral diseases
EA007184B1 (ru) * 2001-04-10 2006-08-25 Пфайзер Инк. Производные пиразола для лечения инфекции вируса иммунодефицита человека (вич)

Also Published As

Publication number Publication date
ATE398607T1 (de) 2008-07-15
ES2305563T3 (es) 2008-11-01
BR0314930A (pt) 2005-08-02
GB0223234D0 (en) 2002-11-13
EP1556359B1 (de) 2008-06-18
JP2006504713A (ja) 2006-02-09
EP1556359A1 (de) 2005-07-27
AU2003264940A1 (en) 2004-04-23
CA2501541A1 (en) 2004-04-15
MXPA05003641A (es) 2005-06-08
WO2004031156A1 (en) 2004-04-15

Similar Documents

Publication Publication Date Title
MY146669A (en) Pyrazole derivatives for treating hiv
NO20055421L (no) Kinolinderivater som fosfodiestrase-inhibitorer
NO20060981L (no) Pyridazinderivater og deres anvendelse som terapeutiske midler
TR200302242T2 (tr) Protein kinaz önleyicileri olarak pirolopirimidinler
NO20070224L (no) 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav
NO20050851L (no) Kaspase-inhibitorer og anvendelser derav
NO20063761L (no) Sulfonamidderivater for behandling av sykdommer
NO20044731L (no) Kinolin- og isokinolinderivater fremgangsmate for fremstilling derav og anvendelse derav som betennelseshemmere
ATE371656T1 (de) Heteroaryl-pyrimidinderivate als jak-inhibitoren
EA200700099A1 (ru) Производные пиридина
NO20070258L (no) Benzyltriazolonforbindelser som ikke-nukleoside revers transkriptase inhibitorer
NO20062983L (no) Sulfonamid-derivater for behandling av sykdommer
ATE527261T1 (de) 7-aryl-3,9-diazabicycloä3.3.1ünon-6-en-derivate und ihre verwendung als renin-inhibitoren zur behandlung von bluthochdruck, herz-kreislauf- erkrankungen und nierenkrankheiten
NO20056192L (no) Kapaseinhibitorer og anvendelse derav
ATE384714T1 (de) Pyrazolderivate
EA200601462A1 (ru) Соединения для лечения заболеваний
NO20050573L (no) 4-'7-halo-2-quino (XA) linyloksy ! fenoksypropionsyrederivater som antineoplastiske midler
BR0314759A (pt) Derivados de pirazol
DE60321700D1 (de) Pyrazolderivate und deren verwendung als therapeutische mittel für durch hiv vermittelte krankheiten
HUP0203161A2 (hu) Benzamidinszármazékok, eljárás az előállításukra, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
BR0314709A (pt) Derivados de pirazol
DK0944618T3 (da) Nye N-benzensulfonyl-L-prolin-derivater, fremgangsmåde til deres fremstilling og deres anvendelse til terapeutiske formål
AP1846A (en) Pyrazole Derivatives.
DK1501823T3 (da) Hidtil ukendte piperidinyl-alkylamino-pyridazinon-derivater, en fremgangsmåde til fremstilling deraf og farmaceutiske præparater der indeholder forbindelserne
NO20064805L (no) Sammensetninger for behandling av sykdommer

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee